$KAST just announced a Joint Venture Agreement with Dakota Life Sciences to develop, fund, and market Site Specific Penetration Technology (SSPT) biopharmaceutical products. http://www.stockonhighalert.com/newsletters/kast-offers-tactical-opportunity-strong-biopharma-trend/